focus -WSS

focus

author：entertainment 2025-09-30 00:45:23 - browse：5

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： What causes an itch? Researchers may have solved the mystery

focus

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

Patients' immediate access to test results puts radiologists in a bind

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

The FDA must approve intranasal treatments for anaphylaxis

After sickle

Teach medical students about patients with intellectual disabilities

Wikipedia

focus

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ahead of JPM, here's who's profiting most in health care

In Memoriam: Notable people who died in 2023

New weight loss drugs work. But how can they best be used?

In Memoriam: Notable people who died in 2023

White House finalizes ITC's import ban of latest Apple Watches

Tori Bowie and the unacceptable rates of Black maternal death

The woman behind the Dana Farber

As demand for Covid shots wanes, Moderna seeks its next success

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

CMS should re

Spinal cord stimulation reduces pain in amputees, study finds

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

3 medical device trends to watch in 2024

Pharma patents targeted by Biden in move to slash drug prices

Feng Zhang CRISPR delivery startup lays off quarter of staff

knowledge

focus

Wikipedia

leisure time